The FDA green-lights Brainlab's mobile version of the TraumaCad surgical planning software for hip replacement procedures.
Brainlab said it won FDA clearance for a mobile version of its TraumaCad surgical planning software for hip replacement procedures.
The product, TraumaCad Mobile, will be marketed by Brainlab's Voyant Health unit. The application is compatible with Mac and PC web browsers plus iOS mobile devices.
Johnson & Johnson's DePuy Synthes subsidiary signs a deal for exclusive rights to Radlink's Galileo positioning system for use with its line of hip replacement implants.
A former associate professor at New York University, Yudong Zhu, reaches a plea deal on charges that he accepted bribes from a Chinese medical imaging company in return for details of his research.
(Reuters) — A former New York University associate professor has reached a plea deal ahead of a trial on charges that he conspired to receive bribes from a Chinese medical imaging company in exchange for information about his federally funded research.
Volcano, now part of Dutch conglomerate Royal Philips, gains a European CE Mark for new software that helps assess serial lesions and diffuse coronary disease in a simpler way.
Cardiovascular imaging company Volcano nailed down a CE Mark in the European Union for diagnostic software that helps assess serial lesions and diffuse coronary disease in a simpler way.
MRI Interventions says it plans to shutter its Memphis operation, laying off all workers there, as it consolidates in California; appoints ex-Pro-Dex honcho Harold Hurwitz as its new CFO.
MRI Interventions (OTC:MRIC) said it plans to shutter its plant in Memphis in May and lay off all the workers there as the consolidates in Irvine, Calif.
Georgia-based Digirad expands its geographical reach by acquiring MD Office Solutions, a mobile-diagnostic services provider focused on the Northern California market.
Wisconsin startup HealthMyne digs up a $4.5 million Series A round for its clinical imaging analytics platform.
HealthMyne said it pulled in $4.5 million in Series A financing to advance development of its clinical imaging analytics platform for cancer clinics.